These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34727932)

  • 1. Medium & long-chain acylcarnitine's relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study.
    Zheng DM; An ZN; Ge MH; Wei DZ; Jiang DW; Xing XJ; Shen XL; Liu C
    Lipids Health Dis; 2021 Nov; 20(1):151. PubMed ID: 34727932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farrerol Alleviates Diabetic Cardiomyopathy by Regulating AMPK-Mediated Cardiac Lipid Metabolic Pathways in Type 2 Diabetic Rats.
    Tu J; Liu Q; Sun H; Gan L
    Cell Biochem Biophys; 2024 Sep; 82(3):2427-2437. PubMed ID: 38878100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus.
    Zhao S; Feng XF; Huang T; Luo HH; Chen JX; Zeng J; Gu M; Li J; Sun XY; Sun D; Yang X; Fang ZZ; Cao YF
    Front Endocrinol (Lausanne); 2020; 11():212. PubMed ID: 32431666
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.
    Zheng Z; Ma T; Guo H; Kim KS; Kim KT; Bi L; Zhang Z; Cai L
    J Cell Mol Med; 2019 Aug; 23(8):5771-5781. PubMed ID: 31199069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization.
    Peng M; Liu L; Jiang M; Liang C; Zhao X; Cai Y; Sheng H; Ou Z; Luo H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():12-8. PubMed ID: 23816563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats.
    Trang NN; Chung CC; Lee TW; Cheng WL; Kao YH; Huang SY; Lee TI; Chen YJ
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association and prediction value of acylcarnitine on diabetic nephropathy in Chinese patients with type 2 diabetes mellitus.
    Li X; Miao Y; Fang Z; Zhang Q
    Diabetol Metab Syndr; 2023 Jun; 15(1):130. PubMed ID: 37330521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDCD4 deficiency ameliorates left ventricular remodeling and insulin resistance in a rat model of type 2 diabetic cardiomyopathy.
    Zhang J; Zhang M; Yang Z; Huang S; Wu X; Cao L; Wang X; Li Q; Li N; Gao F
    BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32371529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.
    Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New mechanism of lipotoxicity in diabetic cardiomyopathy: Deficiency of Endogenous H
    Guo R; Wu Z; Jiang J; Liu C; Wu B; Li X; Li T; Mo H; He S; Li S; Yan H; Huang R; You Q; Wu K
    Mech Ageing Dev; 2017 Mar; 162():46-52. PubMed ID: 27871808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation.
    Wu M; Tan J; Cao Z; Cai Y; Huang Z; Chen Z; He W; Liu X; Jiang Y; Gao Q; Deng B; Wang J; Yuan W; Zhang H; Chen Y
    Redox Biol; 2024 Jul; 73():103184. PubMed ID: 38718533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipsin inhibits Irak2 mitochondrial translocation and improves fatty acid β-oxidation to alleviate diabetic cardiomyopathy.
    Jiang MY; Man WR; Zhang XB; Zhang XH; Duan Y; Lin J; Zhang Y; Cao Y; Wu DX; Shu XF; Xin L; Wang H; Zhang X; Li CY; Gu XM; Zhang X; Sun DD
    Mil Med Res; 2023 Dec; 10(1):63. PubMed ID: 38072993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.
    Guleria RS; Singh AB; Nizamutdinova IT; Souslova T; Mohammad AA; Kendall JA; Baker KM; Pan J
    J Mol Cell Cardiol; 2013 Apr; 57():106-18. PubMed ID: 23395853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermedin Alleviates Diabetic Cardiomyopathy by Up-Regulating CPT-1β through Activation of the Phosphatidyl Inositol 3 Kinase/Protein Kinase B Signaling Pathway.
    Zhao J; Han L; Zhang YR; Liu SM; Ji DR; Wang R; Yu YR; Jia MZ; Chai SB; Tang HF; Huang W; Qi YF
    Pharmaceuticals (Basel); 2024 Sep; 17(9):. PubMed ID: 39338366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification.
    Zoni E; Minoli M; Bovet C; Wehrhan A; Piscuoglio S; Ng CKY; Gray PC; Spahn M; Thalmann GN; Kruithof-de Julio M
    BMC Cancer; 2019 Dec; 19(1):1216. PubMed ID: 31842810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
    Bulani Y; Sharma SS
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):255-267. PubMed ID: 28695302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragalus polysaccharides alleviates cardiac hypertrophy in diabetic cardiomyopathy via inhibiting the BMP10-mediated signaling pathway.
    Sun S; Yang S; Zhang N; Yu C; Liu J; Feng W; Xu W; Mao Y
    Phytomedicine; 2023 Jan; 109():154543. PubMed ID: 36610158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.